Innovative Strategies to Maintain Product Integrity in Biologic and Biosimilar Clinical Studies

Catalent's Mark Woolf discusses some innovative strategies to maintain the temperature-controlled supply chain for clinical trials involving biologic and biosimilar drugs.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: